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CHAPTER I 
 
 
INTRODUCTION 
 
 
 
This study will evaluate the impact of the transition from a standard preterm formula to a 
higher protein preterm formula on infant growth and outcomes, specifically: protein status, 
morbidity, mortality and length of stay in the neonatal intensive care unit (NICU) at St. John 
Medical Center (SJMC) in Tulsa, Oklahoma. The primary goal in caring for the increasing 
numbers of preterm infants is to promote growth equal to that of a similarly aged infant in utero 
(AAP, 2009). Proper nutrition in early stages of life promotes the accrual of lean body mass, 
particularly in organs such as the brain, minimizing detrimental cognitive outcomes (Abernethy, 
Cooke & Foulder-Hughes, 2004; Ehrenkranz et al., 2006; Ehrenkranz, 2000; Smart, 1990).  
Studies have shown a 40% reduction in total brain volume in preterm infants (Abernethy et al., 
2004; Mewes et al., 2006), which can last into adolescence (Isaacs et al., 2008).  Animal models 
indicate reduced neuron length and dendritic connections associated with undernutrition (Smart, 
1990).  Many preterm infants do not match growth of their term counterparts even when born 
appropriate for gestational age. However, preterm infants do have the ability for catch-up growth, 
including in relation to the brain, when provided with adequate protein and energy (Isaacs et al., 
2008).    
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Enfamil Premature 24 Cal formula was used by the St. John Medical Center NICU as 
their standard preterm formula until it was recently redeveloped in response to research on the 
protein needs of neonates (Tsang, Uauy, Koletzko, Zlotkin, 2005; Klein, 2002).  In November 
2010, Enfamil Premature 24 Cal High Protein was introduced to the unit changing the standard 
preterm formula from 3 grams of protein per 100 kcal to 3.5 grams to meet the infant’s nutritional 
needs without the use of modular supplements.  The unit made a full transition to the new product 
by April 2011. As this new high protein preterm formula is based on guidelines provided by the 
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) 
Committee on Nutrition (2010), the Food and Drug Administration approved the production and 
distribution of this product without any clinical trials given that there were only changes to the 
amount of macronutrients, with all ingredients remaining the same (Personal communication, 
Mary Engelland, MEd, RD, CSP, CD Mead Johnson Nutrition, Global Medical Affairs). The new 
formulation continued to fall within the guidelines of the Infant Formula Act requiring the 
minimum level of protein of 1.8 g per 100 kcal and the maximum level of 4.5 g per 100 kcal 
(Federal Food, Drug, and Cosmetic Act, 1980). The purpose of this study was to investigate if 
theoretical outcomes associated with providing higher concentrations of protein to preterm infants 
were true for infants in the unit at Saint John. Specifically; growth, protein status, and selected 
basic outcomes such as, length of stay and morbidity were compared between the two formula 
groups. 
The hypothesis of this study is that those infants in the high protein preterm formula 
group will show better overall growth with no adverse outcomes. The specific objectives of the 
study are:  
I. To evaluate the effect of high protein preterm formula related to the promotion of 
improved growth in the preterm infants admitted to the Saint John Medical Center 
NICU.  Expected outcomes will be: improved growth and a decrease in infants with 
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extrauterine growth restriction (EUGR) as measured by differences in growth plotted 
on the Fenton growth chart from birth to discharge.  
II. To evaluate changes in biochemical markers of protein status in preterm infants on 
different feeding regimens.  With an increase in protein provided, increased levels of 
blood urea nitrogen (BUN) were expected. The BUN should remain stable and 
indicate if the infant is receiving adequate amounts of protein once the infant is on a 
stable fluid regimen and receiving full feeds, defined as an infant receiving 120-150 
ml/kg from feeds.  
III. Morbidity outcomes such as length of stay and incidence of necrotizing enterocolitis 
were evaluated. Mortality was evaluated.  
 The design of the study was a retrospective chart review utilizing a convenience sample at 
St. John Medical Center’s NICU.  Qualifying cases six (6) months prior to the unit’s transition to 
high protein preterm formula in December 2010 and six (6) months after transition to the unit’s 
use of high protein preterm formula, with no more than 60 in either group, were considered.  
Singleton infants with a birth weight between 600 and 2500 grams, and gestation at birth greater 
than 24 weeks and less than 37 weeks, admitted to the NICU during study the period were 
considered in this study.  
 Assistance was needed to identify the subjects for the study from the data collection 
personnel in the St. John Medical Center’s NICU. All data were collected using the electronic 
medical record of the identified cases. The St. John Medical Center Institutional Review Board 
and Oklahoma State University Institutional Review Board approved the study’s methods and 
procedures. 
Summary: 
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adequate growth, but also for optimal brain development (Abernethy et al., 2004; Ehrenkranz et 
al., 2006; Ehrenkranz, 2000; Smart, 1990).  With the use of the high protein preterm formula, 
neonates are closer to meeting their estimated protein goals.  The aim of this study was to 
evaluate if this new formulation increases the growth of infants in the NICU at Saint John 
Medical Center without any adverse outcomes such as an increase in necrotizing enterocolitis, 
elevated BUN levels, increased sepsis rates, or an increase in length of stay. Improving growth 
outcomes in this patient population is important, but only if this is achieved while not causing 
increased incidences of morbidity and mortality.  
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
 
 
In the United States more and more infants are being born prematurely requiring 
admittance to neonatal intensive care units, which are then charged with providing specialized 
care to meet the needs of this fragile population.  Preterm infants are at increased risk for feeding 
problems due to an immature gastrointestinal system, and have higher risk for infections due to an 
underdeveloped immune system. Practitioners have to balance feeding strategies to decrease the 
risk of disease while promoting adequate growth. Many factors are considered in choosing both 
the composition of feeds and the timing and advancement of feeds, including gestational age, 
birth weight and acuity (the level of severity of illness) of the infant. The ultimate goal is to 
promote growth similar to growth of a comparably aged fetus growing in utero (AAP, 2009).  
Section 1 – Prematurity in the United States 
 Prematurity in the United States is a growing problem. According to the 2009 National 
Vital Statistics Report, 12.2% of infants were born pre-term or at less than 37 weeks gestation. 
The majority of these infants are born between 34-36 weeks of gestation, but the 16% of preterm 
infants born at less than 32 weeks are at an increased risk for adverse health outcomes.  Overall,
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There has been a 36% increase over the past 30 years in preterm births (March of Dimes, 2012).  
While rates of preterm birth are increasing so are the survival rates. Infant mortality has greatly 
decreased from ~20 deaths per 1000 births in 1950, to a rate of 6.5 deaths per 1000 births; a 
statistic which has remained fairly stable over the past 10 years (Mathews & MacDorman, 2011).  
The incidence of low-birth-weight infants is currently about 1 out of every 12 live births (Martin 
et al., 2009). An infant born less than 2500 grams would be classified as low-birth-weight and 
while survival rates for these infants are increasing, they are at greater risk for mental retardation, 
learning disabilities, cerebral palsy and vision and hearing loss compared to their term 
counterparts (Cloherty, Eichenwald & Stark, 2008).  The survival rate disproportionally favors 
the older pre-term infants- going from ~99% among infants born 34-36 weeks gestation to ~80% 
in those infants born less than 28 weeks.  In the infant population, 54% of the deaths occur in the 
2% of infants born at less than 32 weeks, with low- birth-weight being one of the three leading 
causes of infant death (Mathews & MacDorman, 2011).  
Section 2 – Nutrition issues associated with prematurity and the importance of adequate 
nutritional care 
As more and more preterm and low-birth-weight infants survive (Mathews & 
MacDorman, 2011; March of Dimes, 2012), neonatal intensive care units are charged with caring 
for this population and addressing their specialized needs.  These specialized needs include both 
feeding difficulties and altered and generally increased nutrient requirements.   
Sub Section 2.1- Feeding Difficulties:  
Preterm infants are at an increased risk for feeding difficulties due to inadequate feeding 
skills (Sankar, Agrawal, Mishra, Deorari & Paul, 2008). Many are not able to feed orally and 
require alternative feeding methods.  Most preterm infants start on parenteral nutrition and make 
a gradual transition to enteral gastric tube feedings.  The ultimate goal is to provide feedings 
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exclusively from the bottle or directly from the breast.  These infants are also at an increased risk 
for significant illnesses in the first few weeks of life, which may take precedence over providing 
enteral nutrition. Nutrient accumulation occurs in the later part of the third trimester, therefore; 
those infants born prior to 37 weeks are unable to build these stores in utero leaving them with 
low body stores at birth. These infants require higher supplementation of nutrients and have 
increased needs to support catch-up growth, including protein, overall energy, calcium, and 
phosphorous among other nutrients. Lastly, due to the immaturity of the gut, they are more likely 
to experience feeding intolerance.  This increases the need for additional nutritional support, 
monitoring, and treatment associated with feeding problems. (Sankar et al., 2008)  
Some of the factors influencing feeding decisions are how premature the infant is due to 
the concomitant immaturity of the gastrointestinal system and time needed to develop prior to 
feeding. At 32-34 weeks the suck swallow breath coordination is developed. Prior to that time, 
infants will need to be fed via orogastric or nasogastric feedings. There is also dysmotility of the 
GI system with decreased production of lactulose, bile salts, pancreatic lipase, GI hormones, and 
peptides.  These infants have an underdeveloped defense against pathogens and careful 
consideration must be taken to decrease possible causes of infection (AAP 2009). 
Feeding has implications beyond growth including the development and general health of 
these infants. According to the Committee on Nutrition from the American Academy of 
Pediatrics (AAP) (2009), the goals of enteral feeding regimens are to decrease and subsequently 
discontinue parenteral nutrition support to minimize associated complications such as cholestasis, 
sepsis, and osteopenia.  Using the gut by providing enteral nutrition also enhances absorption of 
nutrients including: fatty acids, DHA, EPA, calcium, phosphorus, and protein, and can allow for 
the benefits of trophic feeding. The American Academy of Pediatrics (2009) defines trophic feeds 
as providing feedings of formula or breast milk at 1-25 ml/kg/d.  The intention is to provide small 
volume feedings to prime the gut not to provide a major source of nutrition.  This practice used in 
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conjunction with parenteral nutrition (PN) for nutritional support, aids in preventing gut atrophy 
with prolonged NPO status, and helps to establish tolerance prior to providing full feeds. The 
ultimate goal is to transition to and establish tolerance for the type of feeding the infant will be 
sent home on of either formula or expressed breast milk (AAP, 2009).  
Those infants at particular risk for feeding difficulties are those that are less than 32 
weeks gestation and/or very low birth weight infants. These two groups are at an increased risk 
for necrotizing enterocolitis (NEC) (Cloherty et al., 2008). During admission to NICUs these 
infants often experience sub-optimal growth due to restrictions necessitated by the medical 
management of acute illness, and the slow advancement of feeds in an attempt to minimize NEC 
risk (AAP, 2009).  Necrotizing enterocolitis will be discussed in further detail in section 5. The 
balancing act of providing adequate nutrition while admitted to the NICU, while not increasing 
rates of morbidity and mortality is often difficult yet critical for development (Patole & De Klerk, 
2005).  Establishing what nutrients need to be provided and in what quantities to promote growth 
and development is essential for adequate care during an infants’ admission to the NICU.  
Sub Section 2.2 Nutrient requirements:  
Proper nutrition in early stages of life promotes growth and accrual of lean body mass, 
and can promote development in organs such as the brain, minimizing detrimental cognitive 
outcomes (Abernethy et al., 2004; Ehrenkranz et al., 2006; Ehrenkranz, 2000; Smart, 1990). 
Studies have shown a 40% reduction in total brain volume in preterm infants (Abernethy et al., 
Cooke & Foulder-Hughes, 2004; Mewes et al., 2006), which can last into adolescence (Isaacs et 
al., 2008). Animal models indicate reduced neuron length and dendritic connections associated 
with undernutrition (Smart, 1990). These studies implying those infants not receiving proper 
nutrition will likely have poorer neurocognitive development at later stages of development. 
Many preterm infants do not match growth of their term counterparts even when born appropriate 
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for gestational age (AGA). However, preterm infants do have the ability for catch-up growth, 
including in the brain, when provided with adequate protein and energy (Isaacs et al., 2008).  The 
aim is to transition from parenteral nutrition to a feeding that promotes adequate growth, while 
minimizing the risk of complications.  
Energy is needed for the synthesis of new tissue, varying depending on the type of tissue 
being synthesized and stored, and is dependent on the ratio of protein to energy (Kashyap & 
Schulze, 2006).   If energy intake is inadequate, protein will be used as an energy source with 
decreased nitrogen balance. When energy intake is increased, protein is spared and there is an 
increase in nitrogen retention. When protein intake is low, increasing overall calorie intake will 
spare protein, but when there is both increased energy and protein intake weight gain is promoted. 
With increased energy and adequate protein provided, there is an increase in fat deposition and 
positive weight gain (Tsang, Uauy, Koletzko & Zlotkin, 2005).  
Many premature infants, especially those born at very low birth weights, experience 
postnatal growth failure (Ziegler, 2007). According to the Life Sciences Research Office (Klein, 
2002) the optimal protein: energy ratio is 2.5-3.6g/100 kcal. When Tsang et al. (2005) compared 
growth in infants fed varying levels of calories/protein ratios, they found that the infants fed 90 
kcal/kg and 3 g protein/kg accrued the least amount of protein, and those fed 137 kcal/kg and 3.5 
g protein/kg accrued the same amount of protein as those infants fed 104 kcal/kg and 3.8 g 
protein/kg, but those infants in the higher calorie group added nearly twice as much fat. This 
shows there is optimal growth when adequate protein is provided, but when excessive energy is 
provided it is stored mostly as fat.  Traditional preterm formula has 3 g of protein/100 kcal, and 
high protein formula varies from 3.3 to 3.5 g of protein/100 kcal.  
Inadequate nutritional intake in preterm infants has been shown to impair brain 
development in animal models if the deficiencies occur during critical developmental periods 
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(Arslanoglu, Moro & Ziegler, 2006).  In human studies, impaired neurocognitive development 
has been seen with preterm infants not receiving adequate nutrition in the early stages of life. 
(Lucas et al., 1990; Lucas, Morley & Cole, 1998).  These effects were studied up to 8 years of age 
with improved outcomes seen throughout (Gale, O’Callaghan, Bredow & Martyn, 2006).  
The metabolic parameter most often used to evaluate protein status in preterm infants is 
blood urea nitrogen (BUN). With normal renal function a low BUN indicates inadequate protein 
intake. Very high BUN levels suggest possible excessive protein intake (Arslanoglu et al., 2006). 
Monitoring BUN can help to detect inadequate protein intake and be used to identify when 
excessive protein is being provided (Arslanoglu et al., 2006). While the normal range for BUN in 
preterm infants is not well defined, according to Moyer-Mileur, 2000, an acceptable range is 3-25 
mg/dL for preterm infants ≤ 1 week old. No range is provided for those preterm infants ≥ 1 week 
old, but the term range for infants ≥1 month old is 5-18 mg/dl. Other studies that have used BUN 
as a protein indicator set the ideal range for BUN from 9-14mg/dl, with 20mg/dl considered as 
high (Arslanoglu et al., 2006).  
Providing excessive protein could lead to metabolic stress from protein overload and at 
this time biochemical markers for protein status are likely not sensitive enough to identify protein 
toxicity (Tsang et al., 2005).  In 1969, a study showed that when preterm infants were provided 
with >6 grams of protein/kg/d they exhibited signs of azotemia and pyrexia (Goldman, 
Freudenthal, Holland, & Karelitz, 1969).  Excessive protein intake has shown increases in 
ammonia, blood amino acids, and late metabolic acidosis (Raiha, Heinonen, Rassin & Gaull, 
1976)  
The AAP (2009) established nutrient requirements to promote growth at the same rate 
and composition of the fetus of the same gestational age without inducing nutrient deficiency or 
toxicity. Tsang (2005) promotes the use of increased energy and protein to decrease postnatal 
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growth retardation and support catch up growth. ESPGHAN (2010) did not provide guidelines for 
infants greater than 1800 grams and only provided data on protein for infants <1000 grams.  
ESPGHAN (2010) suggests growth should be promoted similar to intrauterine growth, and by 
increasing energy they aimed to increase fat accumulation.  
Sub Section 2.3 Nutritional goals  
While there is no one resource for estimating nutritional goals for preterm infants three 
organizations have provided nutrient ranges.  In the Tsang et al. (2005), guidelines are defined 
using birth weight.  Those infants classified as extremely low birth weight (ELBW) or less than 
1000 grams at birth have the highest nutrient goals, followed by those infants classified as very 
low birth weight (VLBW) or less than 1500 grams at birth. ESPGHAN (2010) also made 
recommendations based on birth weight, while the AAP’s recommendations (2009) are for all 
preterm infants.  Guidelines are outlined in Table 1.  
Table 1: Nutritional goals 
Nutrient AAP 2009 Tsang 2005 ESPGHAN 2010 
Energy kcal/kg 105-130 110-130 VLBW 
130-150 ELBW 
110-135  
Protein g/kg 3.5-4 3.4-4.2 VLBW 
3.8-4.4 ELBW 
3.5-4 infants weighing 1-1.8 kg 
4.0-4.5 infants weighing <1 kg 
 
Sub Section 2.4 Breastmilk and need for preterm formula:  
Research abounds on the benefits of providing breast milk to infants. According to a 
review article by Askin and Diehl-Jones in 2005, evidence shows that providing breast milk to 
term infants can reduce a variety of health problems including: feeding intolerances, the severity 
of respiratory infections, diarrhea, urinary track infections, and meningitis. Other research finds 
that human milk can be protective against type I diabetes, celiac disease, Crohn’s disease, 
allergies, and sudden infant death syndrome (SIDS). Additionally long term effects as improving 
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IQ, decreased inflammation, and increased protection against pathogens have been noted (Askin 
& Diehl-Jones, 2005).  
According to the same article by Askin and Diehl-Jones (2005), these findings can also 
be applied to preterm and very-low-birth-weight. In addition to the previously listed benefits, 
providing breast milk to this group is even more important as preterm human milk has increased 
concentrations of immunoglobulins, and anti-infective components, resulting in an enhanced 
protection from infection including sepsis and meningitis.  The nutrients in breast milk are also 
better absorbed than those in formula including fat, zinc, and iron. Gut function and maturation is 
enhanced by the growth factors present in breast milk in addition to a decreased renal solute load 
in breast milk benefitting the immature kidneys. Lastly, feeding expressed breast milk (EBM) can 
decrease the incidence of necrotizing enterocolitis, which is not only a potentially deadly 
condition, but can be very expensive to treat (Askin & Diehl-Jones, 2005).  
Nearly all infants benefit from the use of their mothers milk prior to any other type of 
feeding. The conclusions of Schanler, Shulman and Lau in a 1999 study, showed that human milk 
improved health by decreasing NEC and late onset sepsis, improved feeding tolerance by 
decreasing gastric residual volume >2 ml/kg/d, or 50% of 3 hour feeding, and also decreased the 
amount of times feedings were held.  Infants on EBM reached full enteral feeds earlier, and were 
discharged from the hospital faster.  One downfall they found to using breast milk was slower 
growth in both length and weight  (Schanler et al., 1999).   
While it is well established that breast milk is best, that is not an option for all moms and 
infants. Most preterm infants do not yet have the skills to successfully feed directly from the 
breast. Without stimulation, it’s often difficult for mothers to maintain their milk supply. The 
release of oxytocin in a lactating mother increases milk volume and aids in milk let-down 
(Anderson et al., 2003a; Anderson, Moore, Hepworth, & Bergman, 2003b). Due to the acuity of 
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most infants it’s not possible for moms to hold their infants as desired therefore decreasing skin-
to-skin contact.  Without this contact, both volume of milk production and duration of 
breastfeeding decline (Anderson et al., 2003a; Anderson et al., 2003b) making it more difficult 
for mothers to provide breast milk.  
There are few contraindications to breast-feeding, which include infants with 
galactosemia, mothers with active tuberculosis, women who test positive for human 
immunodefiency virus (HIV), and some maternal medications (Cloherty et al., 2008).  Mothers 
who have a positive drug screen would also be disqualified from providing breastmilk to their 
infants (Anderson, Wood, Keller & Hay, 2006). Other mothers are physiologically unable, or 
simply choose not to breastfeed.  Because of these situations there is a need for preterm formula 
to be on hand to provide nutrition to preterm infants. Even when breastmilk is available and 
despite its benefits, human milk is often unable to provide enough energy and protein to promote 
optimal growth. Fortification is needed to meet infants elevated estimated needs (Tsang et al., 
2005).   
The Infant Formula Act of 1980 provided guidelines and regulations for the 
manufacturing of formula in the United States. It was amended in 1986 to provide the 
government with more power to ensure the requirements for quality were being met.  This set of 
laws did not account for preterm needs. In 2002, the Life Sciences Research Office of the 
American Society for Nutritional Sciences (Klein, 2002) released a report after the FDA 
requested recommendations for preterm infants. The preterm formula developed and used in most 
NICU’s was based on a 24 kcal/oz ratio with 3 g protein/100 kcal.  In response to research on the 
protein needs of neonates, (Tsang et al., 2005; Klein, 2002) a new higher protein formula was 
developed and released in November 2010 changing the traditional preterm infant formula from 3 
g protein/100 kcal to 3.5 grams to meet the nutritional needs without the use of modular 
supplements. While this new high protein preterm formula is based on guidelines provided by the 
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ESPGHAN Committee on Nutrition (2010), the Food and Drug Administration (FDA) approved 
the production and distribution of this product without any trials, as there were only changes to 
the amount of macronutrients, not type of ingredients (Personal communication, Mary Engelland, 
MEd, RD, CSP, CD Mead Johnson Nutrition, Global Medical Affairs). The new formulation 
continued to fall within the guidelines of the Infant Formula Act requiring the minimum level of 
protein of 1.8 g per 100 calories and the maximum level of 4.5 g per 100 calories (Federal Food, 
Drug, and Cosmetic Act, 1980).  
While breast milk is the standard when it comes to feeding all infants including preterm 
infants, it isn’t nutrient dense enough in most situations to promote adequate growth (Tsang et al., 
2005).  Table 2 compares breast milk to formulas designed to meet preterm infants nutritional 
needs.   
Table 2: Nutrition provided in specialized formulas compared to standards 
Nutrient per 
kg/d 
AAP 
2009 
EBM** EBM+ 4 
pkt HMF/ 
100ml** 
Premature 
Formula* 
High 
protein  
Preterm 
3.3 g/100 
kcal** 
High 
protein 
Preterm 
3.5 g/100 
kcal* 
Discharge 
Formula* 
Term 
Formula* 
Volume (ml)  150 150 150 150 150 150 150 
Energy (kcal) 105-130 100 120 120 120 120 110 100 
Protein (g) 3.5-4 1.4 2.9-3 3.6 3.96 4.2 3.4 2.4 
*Mead Johnson Nutrition Pediatric Products Handbook 2011 
** Abbott Pediatric Nutrition Product Guide 2011 
Section 3: Goals for adequate growth  
Growth is measured by gains in weight, length, and head circumference. The goal is to 
promote growth at the same rate as in an infant of the same gestational age in utero (AAP, 2009).  
Nutrient requirements for preterm infants are much higher than those of term infants to promote 
adequate growth.  How to establish exactly what those requirements are has long been debated, 
and several approaches have been used to attempt to define these requirements. The 
distinguishing factor is to what extent to account for catch-up growth (Zielger, 2007).  Several 
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large studies comparing actual growth in preterm infants found average weight gain ranged from 
14.9g/kg/d reported by Lubchenco, Hansman, Dressler and Boyd in 1963 to 20 gm/kg/d reported 
by Alexander, Himes, Kaufman, Mor & Kogan in1996, with Ehrenkranz et al. 1999 showing 14-
16 gm/kg/d and Klein in 2002 reporting 16-17 g/kg/d.  Guidelines provided in the Nutritional 
Care for High Risk Newborns (1994) state premature infants should be gaining 10-30 grams/day 
with an 0.8-1.1 cm/week gain in both length and head circumference (Catrine, 2000).  In 2007, 
Ziegler reported guidelines for weight gain based on the infants’ birth weights using data from 
Kramer et al, 2001 (Griffin, 2007). The lower the infants body weight is, the larger gains in 
gm/kg/d; for an infant weighing 500-700 grams, goal weight gain is 21 gm/kg/d, ranging to 
infants current weight of 1800-2000 grams with a goal weight gain of 14 gm/kg/d (Ziegler, 2007).  
Being able to provide adequate nutrition is essential in prevention of postnatal growth failure and 
also promotes optimal neurodevelopmental outcomes (Zielger, 2007).  
The most commonly used chart for plotting preterm infants growth is the Fenton growth 
chart (Fenton, 2003).  It is based on a Babson and Benda fetal growth chart published in 1976 
which was widely used for tracking preterm infants’ growth on a graph, prior to the updated 
Fenton.  Several weaknesses of the Babson and Benda chart were the graph was based on a small 
sample size with limited data, and the graph started at 26 weeks gestation limiting it’s usefulness 
for younger infants. It also had 500 gram increments making plotting infants’ growth more 
difficult. A meta-analysis of literature on the growth of preterm and post term infant was 
completed looking at data from 1980-2002.  Four data sets were identified for use including fetal 
weight gain data from Kramer et al. 2001, which included 676,605 infants, 22-43 weeks 
gestation, born in Canada from 1994-1966.  Two studies were included for data on fetal length 
and head circumference; one (Niklasson, Ericson, Fryer, Karlberg, Lawrence & Karlberg, 1991) 
was based on 376,000 Swedish infants, 28-40 weeks gestation, born from 1977-1981, and another 
by Beeby, Bhutap, and Taylor in 1996 which was based 22-40 week gestation infants born 
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between 1982-1995 with information on 29,090 infants’ head circumference and 26,973 infants’ 
lengths.  Lastly, information the CDC had collected from 1963-1994 was used.  CDC had data on 
2,200 to 38,000 subjects per year including infants with varying racial and ethnic backgrounds, 
and included information on infants who were both breastfed and formula fed. This data was 
cross sectional and longitudinal. (Fenton, 2003).  The advantages of this new preterm growth 
chart were a large sample size, more up-to-date data, a range of gestation ages from 22-50 weeks, 
and smaller (100 gram) increments to ease plotting (Fenton, 2003).  Due to the Fenton’s 
strengths. it’s one of the most widely used charts for tracking weight gain.   
Infants are plotted on this chart not just to evaluate individual growth, but also to evaluate 
if the infant falls below the 10 percentile indicating growth restriction (Cloherty et al., 2008).  If 
an infant is born at less than the 10 percentile, they are classified as small for gestational age 
(SGA) or intrauterine growth restriced (IUGR) (Cloherty et al., 2008).  If an infant falls below the 
10 percentile after birth, they are considered to be exrauterine growth restriced (EUGR) (Clark, 
Thomas & Peabody, 2003).   
To prevent growth failure, Table 3 shows accepted overall guidelines and goals for 
preterm infant growth. With these gains, adequate growth should be achieved to promote gains 
similar to those seen in utero (Baylor College of Medicine Section of Neonatology, 2009).  
Table 3: Growth rate guidelines 
Growth Average 
Weight Infants <2 kg 10-20 g/kg/d 
Weight Infants >2 kg 20-30 g/d 
Head Circumference 0.8-1 cm/wk 
Length 0.8-1.1 cm/wk 
Modified from Baylor College of Medicine Section of Neonatology (2009) Guidelines for Acute 
Care of the Neonate.  
	   Meeting growth guidelines depends on providing adequate nutrition, but nutritional goals 
can vary depending on the acuity of the infant or the infant’s particular disease state that affects 
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growth, nutritional and fluid needs. Knowing initial acuity and gestational age can aid clinicians 
in determining appropriate course of treatment (Cloherty et al., 2008).   
Section 4 – Determining acuity and gestational age 
The Apgar system of evaluating infants at birth was proposed by Virginia Apgar in 1953 
to focus on the initial clinical state of the infant. It is most useful in establishing if resuscitation 
should be performed or not. The assessment focuses on heart rate, respiratory effort, reflex 
irritability, muscle tone and color, and each symptom is assigned a number 0, 1, or 2 depending 
on the presence, absence and degree of each of these indicators. In the original report, Apgar 
(1953) found an inverse relationship between the Apgar score and neonatal death. Infants with 
poor scores, from 0-2 had mortality rates of 9-14%, scores from 3-7 mortality of 1.1-2% and 
scores of 8-10 had the lowest mortality rates of 0.13-1%.  These finding were later reinforced 
with a follow up study in 1960 (Apgar & James, 1962).   
Classifying neonates based on gestation age is more meaningful than classifying them 
based on birth weight, as they are more likely to possess qualities of infants similar in gestational 
age opposed to other infants of similar weight (Cloherty et al., 2008).  Gestational age is also the 
most significant predictor of survival in this population (Ballard et al., 1991). Gestational age is 
typically estimated based on the first day of the last menstrual period. Confirmation by ultrasound 
can be made using the fetal crown-rump length during the first trimester. Infants can be classified 
as preterm if they are less than 37 weeks of gestation, and term if they are 37 to less than 42 
weeks gestation. When using weight to classify, infants are said to be normal weight if they are 
greater than 2500 grams at birth, low birth weight (LBW) if they are less than 2500 grams, very 
low birth weight (VLBW) if they are less than 1500 grams, and extremely low birth weight 
(ELBW) if they are less than 1000 grams. 
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The New Ballard Score was developed to aid health care professionals in evaluating 
gestational age, especially for infants born to mothers with unreliable menstrual history or no 
prenatal care. Ballard is the most commonly used score for estimating gestational age, and was 
expanded in 1991 to be more accurate in evaluating those infants with a gestational age of less 
than 28 weeks (Ballard et al., 1991).  The scoring system was expanded by close examination of 
neurological and physical characteristics of extremely premature infants, even those considered to 
be nonviable. These evaluations were compared to those of term infants noting differences in 
flexibility, which allowed the expansion of the neuromuscular maturing scale to include -1.   
Premature infants were noted to have sticky, transparent skin, and to be free of any lanugo, with 
imperceptible breast markings and little differentiation of the genitals.  These indications allowed 
the expansion to the score of -1 for the physical items. When the New Ballard Score was tested, 
researchers found that gestational age was overestimated by 2-4 days in infants less than 37 
weeks, while gestational age was accurate for infants between 32-37 weeks (Ballard et al., 1991).  
Having an accurate gestational age directs the care of this population by identifying expected 
feeding behavior.  Many feeding decisions are based on an infants presumed maturity to identify 
those at greater risk for morbidity and mortality.   
Section 5 – Nutrition and neonatal morbidity 
While most infants admitted to the NICU do not face additional morbidities besides the 
effects of prematurity, they are at increased risk for disease that alters growth and nutrition. Some 
of these diseases are necrotizing enterocolitis, which is an inflammatory bowel disease, sepsis (or 
an infection of the blood) and broncopulmonary dysplasia and chronic lung disease.  
Sub Section 5.1 Necrotizing enterocolitis   
Necrotizing enterocolitis (NEC) is a bowel disease characterized by acute intestinal 
necrosis syndrome of unknown etiology (Cloherty et al., 2008).  It is the most common neonatal 
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intra-abdominal emergency occurring in 1 to 3/1000 live births, requiring surgery in 20-40% of 
cases, and leading to mortality in 10-30% of cases (Barclay, Stenson, Simpson, Weaver & 
Willson, 2007).  The primary risk factor for NEC is prematurity with greater than 90% of cases 
occurring in infants less than 36 weeks of gestation (Henry & Moss, 2009) with the mean age of 
occurrence between 30-32 weeks (Cloherty et al., 2008).  As gestational age decreases, mortality 
increases. Other risk factors include low birth weight (with less than 10% of cases occurring in 
infants weighing more than 2000 grams (Guthrie et al., 2003)), the initiation of enteral feedings, 
or a hypoxic or hemodynamic insult (Cloherty et al., 2008).  NEC most commonly presents with 
bloody stools, abdominal distention, increased gastric residuals, abdominal tenderness or redness, 
a lack of bowel sounds, or a dusky discoloration of the abdominal wall.  It has three stages based 
on severity using Bell’s staging of NEC (Bell et al., 1978). In a study by Caplan, Simon, and 
Jilling (2005), infants diagnosed with NEC had an increased length of stay in the NICU, a higher 
likelihood of having short gut syndrome, and abnormal neurodevelopment. 
Strategies suggested to prevent NEC include an increased use of human milk versus 
formula, using a lower milk volume and advancing the feedings slower, and using products with a 
low osmotic load (Bhatia, 2010). Low osmotic load products have been shown to decrease transit 
time, therefore helping to avoid substrate fermentation related to the infants’ slow motility and 
poor digestion. The use of pre- and probiotics may also be beneficial even though research is 
limited on the safety of this practice.  
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Table 4: Bell stages of necrotizing enterocolitis 
Modified from Bell et al. 1978 
Sub Section 5.2 Late onset sepsis 
Neonatal Late Onset Sepsis is defined as a bacterial infection occurring from 8-90 days of 
life, and is diagnosed by positive blood culture for gram-positive, gram-negative, or fungal 
infection (Cloherty et al., 2008).  Up to 21% of infants admitted to the NICU develop sepsis with 
mortality in 18% of those infants diagnosed.  Some of the risk factors for sepsis are infants 
Stage Systemic Signs  Intestinal Signs  Radiologic Signs  Treatment 
1: Suspected Temperature instability, 
apnea, bradycardia 
Elevated 
pregavage 
residuals, mild 
abdominal 
distension, occult 
blood in stool 
Normal or mild 
ileus 
NPO, antibiotics 
for 3 days 
2: Definite Same as stage 1, plus 
mild metabolic acidosis, 
mild thrombocytopenia 
Same as 1, plus 
absent bowel 
sounds, definite 
abdominal 
tenderness, 
abdominal 
cellulitis, right 
lower quadrant 
mass 
Ileus, pneumatosis 
intestinalis plus 
portal vein gas, 
with or without 
ascites 
  
NPO, antibiotics 
for 7-14 days 
depending on 
severity 
3: Advanced Bowel intact: Same as 
stage 2, plus 
hypotension, 
bradycardia, respiratory 
acidosis, metabolic 
acidosis, disseminated 
intravascular 
coagulation, neutropenia 
Bowel perforated: Same 
as above 
Bowel intact: 
Same as stage 2, 
plus signs of 
generalized 
peritonitis, marked 
tenderness and 
distension of 
abdomen. 
 Bowel perforated: 
Same as above 
Bowel intact: Same 
as stage 2 plus 
definite ascites 
                             
 
Bowel perforated: 
Same as above  
plus 
pneumoperitoneum 
Bowel intact: 
NPO, antibiotics 
for 14 days, fluid 
resuscitation, 
inotropic support, 
ventilator therapy, 
paracentesis 
Bowel perforated: 
Same as above, 
plus surgery 
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weighing less than 1500 grams, those with the presence of central lines, the prolonged use of 
TPN, delayed enteral feeding, mechanical ventilation, bronchopulmonary dysplasia, patent ductus 
arteriosus, and a diagnosis of NEC.  Due to the increased risk of sepsis, one of the primary 
nutritional care objectives is to reduce time on parenteral nutrition support while concurrently not 
increasing the risk for necrotizing enterocolitis.  
Sub Section 5.3 – Broncopulmonary dysplasia and chronic lung disease 
Broncopulmonary dysplasia (BPD), also known as chronic lung disease of prematurity 
(CLD), is defined as an infant born less than 32 weeks gestation who remains on oxygen support 
for the first 28 days of life. Infants born less than 1250 grams are the most susceptible, with a 
decreased risk in African-Americans and girls (Cloherty et al., 2008). There are approximately 
3,000 to 7,000 cases of BPD/CLD per year. Mortality is estimated in 10-20% of infants during 
the first year of life, often due to infection. Early growth failure can result from an increase in 
energy needs due to increased work of breathing and inadequate intake for growth. Energy needs 
continue to be increased even after clinical symptoms have resolved (Bhakta & Stark, 2006). 
Growth failure is more severe in lower birth weight infants and can continue in 33-66% of these 
infants up to 2 years corrected age.  The degree of growth failure is influenced by the duration 
and severity of CLD with weight being the most affected and head circumference being the least 
affected (Cloherty et al., 2008).  
Section 6- Summary 
 The number of infants born preterm in the United States continues to rise (March of 
Dimes, 2012).  These infants are not yet fully developed and have increased feeding difficulties 
which can lead to poor growth.  Premature infants are also at increased risk for morbidity, which 
can significantly affect growth. The importance of adequate feeding to promote growth is 
essential for long-term development.  This study evaluates a particular strategy to improve these 
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outcomes by increasing the protein provided in the diet while the infants are admitted to the 
NICU.    
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CHAPTER III 
 
 
METHODOLOGY 
 
 
 
Section 1 – Background and design 
 The design of this study is a retrospective chart review utilizing a convenience sample from 
the St. John Medical Center (SJMC) NICU.  Data used for the study was collected from the 
electronic medical record (EMR). This study qualified for a waiver of consent as this project is 
retrospective and no identifying data were collected The St. John Medical Center Institutional 
Review Board and the Oklahoma State University Institutional Review Board approved the 
study’s methods and procedures (see Appendix 2).  
 
Section 2 – Sample 
All singleton infants with birth weight between 600 and 2500 grams and gestational age 
between 24 and <37 weeks were eligible if admitted to St. John’s NICU between the dates of 
June 1, 2010  to September 31, 2011, excluding the months of December 2010 to March 2011. 
The excluded months were to allow time for the unit to transition fully from traditional preterm 
formula (TPF) to high protein preterm formula (HPF).   
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NICU research personnel provided the PI with a list of infants admitted to unit during 
study period for screening. Infants were included if they received feedings of breast milk, TPF or 
HPF.  Infants excluded were those with major congenital abnormalities, and/or chromosomal 
aberrations.  All others were included in the study. There were 78 qualifying cases in the six 
months prior to the unit’s transition to HPF in December 2010 and 54 qualifying infants in the six 
(6) months after transition to sole use of HPF.  The maximum number in each group was set at 
60.  In the traditional preterm formula group all 35 infants born at less than 2000 grams were 
included.  The first 25 infants born between 2000 grams and 2500 grams were also included as no 
pattern could be established in list of infants provided therefore the first 25 were considered to be 
selected at random.  .    
 
Section 3 - Materials 
 All information was obtained from review of the infant’s electronic chart. One spread sheet 
was used to collect initial information including, gender, race, Apgar score, Ballard score, 
gestational age, birth weight, length, and head circumference in addition to the infants initial 
percentage on the Fenton growth chart. Discharge weight, length, and head circumference, and 
percent on Fenton growth chart at discharge were also collected. Information on morbidity and 
mortality was obtained using the discharge or death summary along with an official diagnosis by 
the neonatologist.  
 A second spreadsheet was used to track multiple points of data on the same infant during 
their entire stay. This data was collected to monitor growth, changes in type of feeding, tolerance 
of feeding and protein status.  The phase of feeding was recorded indicating if the infant was on 
full TPN support, in the transitional stage weaning off of TPN as feedings were advanced, or on 
full feedings defines as feedings of 120-150 ml/kg (AAP, 2009).  Data on what type of formula 
was used and the tolerance of that formula was collected.  Once an infant was on full feedings, 
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information on blood urea nitrogen was collected weekly along with weight, and head 
circumference. Initially length was to be collected, but limited information was available on 
length in the majority of the charts reviewed; for example in the traditional preterm formula 
group only 20 out of the sample of 60 had discharge lengths.  Creatinine was also to be collected; 
however upon review of the medical records laboratory results for creatinine were missing 
therefore could not be included.  
 Once all the data was initially collected, the PI cleaned the data set. All values that looked 
to be potential errors were marked and that chart was review for a second time to confirm 
accuracy and changes made as appropriate    
Section 4 – Evaluation of growth 
 Growth was measured by comparing birth weight to discharge weight, and birth head 
circumference to discharge head circumference. To evaluate differences in extrauterine growth 
restriction each infant was plotted on the Fenton growth chart at birth. If the infant was plotted at 
<10th %ile, the infant was considered to be small for gestational age (SGA) or intrauterine growth 
restricted (IUGR).  Each infant was plotted again on the Fenton growth chart at discharge, those 
infants plotting at <10% were classified as extrauterine growth restricted (Clark et al. 2003).  
Daily weights and head circumferences were also obtained along with the feeding that was being 
provided to track weight gain associations with formula type.  
Section 5 – Evaluation of protein status 
 The metabolic parameter used to evaluate protein status was blood urea nitrogen (BUN).  
With normal renal function, blood urea nitrogen will indicate low protein intake and when levels 
are very high can also indicate excessive protein intake (Moro et al., 1995).  Normal range for 
BUN in preterm infants is not well defined, but in this study 9-20 mg/dL was considered within 
normal limits (Nutritional Care for High-Risk Newborns, 1994). Infants were screened for 
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abnormal renal function and data was only collected once the infant reached full feds of 150 
ml/kg and fluid intake was stable 
Section 6 – Assessment of acuity and gestational age 
 Two types of scores were used to indicate the infant’s health status and gestational age.  
Apgar: 
 Apgar scores were collected to provide initial information on acuity of the infant. The 
assessment focuses on heart rate, respiratory effort, reflex irritability, muscle tone and color, and 
is assigned a number 0, 1, or 2 depending on the presence, absence and degree of each of these 
indicators. Scores range from 0-10 with decreased values associated with a lower survival rate 
(Apgar, 1953).   
Gestational age: 
 Information to estimate gestational age was collected from the infants chart based on what 
the mother had reported and based on the mothers prenatal care and estimation from her 
physician.  It was not indicated if this was based on the last day of her menstrual cycle, or based 
on an estimate by ultrasound of rump-crown length.  Infants < 37 weeks are considerer preterm, 
and all infants included were <37 weeks.  Of the 114 infants in the study, 110 had a new Ballard 
Score assessment within the first 96 hours of life.  Scores range from -10 to 50, indicating an 
estimated gestational age of 20-44 weeks gestation based on neuromuscular and physical maturity 
(Ballard et al., 1991). Both gestational age and Ballard score were collected in this study.  
 
Section 7 – Morbidity and mortality 
 Three types of illness particularly common in preterm infants were tracked and data on 
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survival to discharge were also collected.  
Necrotizing enterocolitis and sepsis: 
 Each qualifying infant’s discharge summary was reviewed for official diagnoses of 
necrotizing enterocolitis and sepsis made by the neonatologist. Only cases of confirmed 
necrotizing enterocolitis, stage 2 or 3 were included in the study and designated as surgical or 
non-surgical.  
 Sepsis was defied as a positive blood culture after day of life 7. All blood cultures were 
analyzed in the hospital’s laboratory. Official diagnosis by the neonatologist in the discharge 
summary was also used to confirm the finding.  
Broncopulmonary dysplasia and chronic lung disease: 
 Each qualifying infant’s discharge summary was reviewed for official diagnoses of 
broncopulmonary dysplasia (BPD), chronic lung disease (CLD), or both made by the 
neonatologist. Infants that remained on respiratory support for 28 days or more were diagnosed 
with broncopulmonary dysplasia or chronic lung disease. These infants are indicated in the study 
due to alterations in growth due to increased work of breathing.  
Morality: 
 Specifics of the infants’ death were collected from the neonatologist death summary report.   
 
Section 8 – Statistical analysis 
 SPSS version 19.0 was used to analyze the data. Descriptive statistics, including 
frequencies, means and standard deviation, were computed from gender, race, Apgar Score, 
Ballard Score, gestational age, mortality, and birth and discharge weight, length, head 
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circumference, and percent on Fenton growth chart. Independent two sample T-test analysis was 
done to compare the differences between the two groups of infants. Chi Square tests were used to 
evaluate NEC, and BPD/CLD.  Difference in groups were considered significant at p <0.05.   
HLM2, Hierarchical Linear and Nonlinear Modeling, also referred to as multilevel 
models, were used to evaluate the effect of high protein preterm formula on growth and BUN 
status.  This program is used to show hierarchical relationships by arranging variables into 
groups.  The program then evaluates the influence other groups of variables on each other. In this 
study level 1 and level 2 units were used. This allowed for evaluation of the relationships of 
several variables at both levels to be used in a single analysis. It takes into account variations at 
each level, by estimating the model coefficients at each level and predicts the random effects 
associate with each sampling unit at each level.  Repeated measures for each infant were 
evaluated.  Baseline was established using growth from all other infants in the study that did not 
receive the traditional preterm formula or the high protein preterm formula.  Multiple regression 
analysis was used to compare expected weight gain and BUN comparing infants who received 
traditional preterm formula, or high protein preterm formula from expected growth of the baseline 
infants, who received breastmilk or specialized formulas. Significance was determined as p 
<0.05.   
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CHAPTER IV 
 
 
RESULTS 
 
 
 
This study examined the effect on growth and protein status comparing the infants 
receiving traditional preterm formula to infants receiving a new formula with a higher protein 
content.  The growth was evaluated using weight data, which was collected periodically during 
each infant’s admission.  Protein status was evaluated using blood urea nitrogen (BUN) from 
laboratory values assessed after the infant was on full feedings, or feedings of 120-150 ml/kg. 
There were two groups in this study, one admitted during the study period prior to St. John 
Medical Center’s NICU transition from the traditional preterm formula (TPF), the other after the 
introduction and transition to a redeveloped higher protein preterm formula (HPF). Data were 
collected to determine to what extent the infants in each formula group were similar or different 
in terms of growth and protein status, with expected improvements for those infants in the high 
protein preterm formula group with no adverse outcomes.   
 
Section 1 – Demographics of study sample 
 
The infants in this sample were predominately white (84.7%) in the traditional preterm
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formula group (TPF) and (75.9%) in the high protein preterm formula group (HPF), with 6.7% 
and 13% of the sample reporting African American ethnicity in the TPF and HPF groups 
respectively as you can see in Table 5.  There was a mean age of 31.1 ± standard deviation (SD) 
of 3.2 weeks gestation in the TPF and 31.5 ± SD of 3.2 weeks gestation in the HPF.  There were 
more boys admitted during the study period (51.7%) in the TPF and (64.8%) in the HPF group, 
which is to be expected as rates of prematurity are higher in boys than girls (Carrascosa, Yeste, 
Copil, Almar, Salcedo & Gussinye, 2004).  Figure 1 shows the majority of infants in the TPF 
(68%) and in the HPF (64%) were classified as low birth weight (<2500 gm).  In the TPF group, 
at full feeds 15/60 infants received preterm formula exclusively or preterm formula that 
transitioned to discharge formula prior to discharge. 11/60 received preterm formula and 
breastmilk and 30/60 received only breastmilk or a specialized formula product and 4/60 infants 
died prior to reaching full feeds.  In the HPF group, at full feeds 12/54 infants received preterm 
formula exclusively or preterm formula that transitioned to discharge formula prior to discharge. 
10/54 received preterm formula and breastmilk and 28/54 received only breastmilk or a 
specialized formula product, and 4/60 infants died prior to reaching full feeds 
 Table 5: Demographic features 
Variable TPF [n(%)] HPF [n(%)] 
Race    
    White     50 (84.7)     41 (75.9) 
    African American     4    (6.7)     7    (13.0) 
    Hispanic     1    (1.7)     3    (5.6) 
    Other      4    (6.7)     2    (3.7) 
    Missing  1 (could not be identified) 1 (could not be identified) 
Gender    
    Male     31  (51.7)     35  (64.8) 
    Female     29  (48.3)     19  (35.2) 
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Figure 1: Classification of weight 
 
 
Extrauterine Growth Restriction:  
Growth restriction was established by evaluating where each infant plotted on the Fenton 
growth chart at birth and then again at discharge. If the infant fell below the 10th percentile at 
either time, growth failure was identified. As seen in Figure 2, there were increases in growth 
failure in both groups. Growth restriction increased from 10% to 34% in the TPF group and 13% 
to 36 % in HPF group. However, there was no statically significant difference between the TPF 
and the HPF groups in regards to EUGR rates based on chi-squared testes with p  = 0.49.  
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Figure 1: Infants defined as ELBW with birth weights <1000 grams, VLBW with birth weights 
from 1000-<1500 grams, and LBW with a birth weight from 1500 grams to <2500 grams.  The 
majority of infants in both groups fall within the LBW category.   
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Figure 2: Small for gestational age/ intrauterine growth restriction vs. extrauterine growth 
restriction   
 
 
 
Rates of necrotizing enterocolitis were similar between the two groups with 6 cases in 
each group, shown in Table 7.   
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Figure 2: SGA- Small for gestational age, IUGR- intrauterine growth restricted, EUGR- extrauterine growth 
restricted. In each growth more infants were discharged growth restricted or <10th percentile than were born 
growth restricted.  
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Section 2- Relationships between groups 
Table 6: Descriptive variables 
 TPF HPF  
Variable n (Mean±SD) n (Mean±SD) p Value 
Apgar 1 59 6.39 ± 1.7 54 6.78 ± 2.0 0.265 
Apgar 5 59 8.02 ± 0.8 54 8.11 ± 1.1 0.614 
Ballard 60 18.8 ± 7.7 54 20.1 ± 7.1 0.366 
GA (wk) 60 31.1 ± 3.2 54 31.5 ± 3.2 0.469 
BW (gm) 60 1625 ± 528 54 1703 ± 535 0.433 
d/c wt (gm) 58 2777 ± 616 52 2518 ± 464 0.014 * 
Fenton % birth 60 41.6 ± 23.3 54 42.8 ± 25 0.786 
Fenton % d/c 58 20.2 ± 17.6 52 21.1 ± 20.4 0.798 
Length birth (cm) 58 40.5 ± 4.6 51 40.9 ± 4.4 0.615 
FOC birth (cm) 60 28.5 ± 3.1 54 28.8 ± 2.8 0.583 
FOC d/c(cm) 55 32.9 ± 1.8 52 32.5 ± 1.9 0.252 
LOS 60 50.7 ± 38.8 54 39.7 ± 30.8 0.099^ 
^ p < .10. * p < .05.  
 	   
Independent sample T-test were used to compare the means between the two groups on: 
Apgar score at 1 and 5 minutes, Ballard score, gestational age, birth length, length of stay, and 
birth and discharge weight, head circumference, percentile on Fenton growth chart.  Analysis did 
not show statistically significant differences between the two groups, with the exception of 
discharge weight where the average discharge weight was 2777 ± 616 g in the TPF and a 
discharge weight of 2518 ± 464 g in the HPF group with a p value of 0.014, as seen in Table 6.  
Length of stay was marginally significant p < 0.1. Infants in the TPF group were 
discharged at a higher weight, and also were admitted to the unit for longer.  All other variables 
did not differ, including morbidity, initial acuity indicated by Apgar scores, gestational age 
reported or assessed with the Ballard.  Birth length or head circumference (FOC) at birth or 
discharge did not differ.   
Table 6: GA- gestational age, BW- birth weight, d/c wt- discharge weight, FOC- head 
circumference, LOS- length of stay.  
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The two groups did not differ in terms of morbidity and mortality, Table 7.  Sepsis was 
marginally significant with p< 0.10. More infants the TPF were diagnosed with sepsis.   	  
Table 7: Morbidity between groups 
  TPF HPF  
Variable  n [n(%)] n [n(%)] p Value 
Mortality  60 3 (5) 54 3 (5.6) 0.609 
BPD/CLD BPD 60 6 (10) 54 5 (9.3) 0.891 
 CLD 60 6 (10) 54 8 (14.8)  
 both 60 1 (1.7) 54 1 (1.9)  
NEC Stage 1 60 4 (6.7) 54 1 (1.9) 0.209 
 Stage 2 60 2 (3.3) 54 5 (9.3)  
Sepsis  60 12 (20) 54 5 (9.3) 0.088^ 
Using Chi-Squared  ^ p < .10. * p < .05.  
Section 3 – Test hypothesis 
Growth:  
Hierarchical linear modeling was used to evaluate the differences between the infants that 
received traditional preterm formula, and those that received high protein preterm formula, each 
compared using the difference between birth weight and discharge weight. Each case was coded 
for the use of high protein preterm formula, traditional preterm formula, or other feeding product. 
Coding accounted for if the infant was on formula on one particular day and also for cumulative 
use of the product.  Exploratory analysis was used to identify potential level 2 predictors as 
necrotizing enterocolitis, sepsis, and gender.  The initial Ballard score (an indicator of the infant’s 
maturity), initial Fenton %, and head circumference at birth were used to establish the y intercept 
and predict weight gain differences.  To determine the slope of the line for day of life, NEC had a 
negative impact on weight gain as did sepsis, and female gender.   
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Table 8: Predictors of infants’ weight gain  
______________________________________________________________________________ 
Predictor Coefficient t-value 
______________________________________________________________________________ 
Intercept 1513.57 86.52***  
Ballard 35.99 7.59*** 
% on Fenton 3.30 4.36*** 
FOC@Birth 100.50 8.71*** 
Day of Life 24.48 29.34*** 
NEC X Day of Life -2.16 -2.18* 
SEPSIS X Day of Life -2.70 -1.88^ 
Female X Day of Life -2.92 -2.68** 
Days on HPF 8.39 4.82*** 
Days on TPF 0.45 0.44 
______________________________________________________________________________ 
Note: df’s = 110, except for df’s =1505 for last two coefficients. 
^ p < .10. * p < .05. **P < .01. *** P < .001. 
As seen in Table 8, the over all effect was an 8.4 gram per day increase in weight for 
each day the high protein product was used, and a 0.45 gram increase in weight gain for each day 
the traditional protein product was used compared to infants on breast milk or other formulas 
(baseline) as seen in the coefficient for the day on HPF and days on TPF respectively.  
This graph in Figure 3 was created using the equation created for the analysis of weight 
gain between the two groups using a representative infant receiving formula starting on day of 
life (DOL) 15.  That infant would then have received the formula for 10 consecutive days at 
which time they changed to the baseline feeding.  It illustrates the expected increase in weight 
over the course of that infants stay.  
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Figure 3: Weight gain increases with high protein preterm formula  
 
 
BUN:  
BUN was also evaluated using hierarchical linear modeling.  The y-intercept was based 
on birth weight and the slope was determined by the interaction between DOL day of life and  
birth weight, which negatively affected the slope. The same coding for formula used to establish 
the cumulative days on TPF or HPF use in the weight gain model was used in this analysis.  
In Table 9, every day the infant received high protein preterm formula there was an 
increase in the BUN of 0.16 mg/dL above baseline, seen as the coefficient of Days on HPF.     
Baseline was determined using all infants that were not on preterm formula or the high protein 
preterm formula. These infants received breast milk, fortified breast milk, and others types of 
formula during their admission to the unit.   
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Table 9: Predictors of blood urea nitrogen 
______________________________________________________________________________ 
Predictor Coefficient t-value 
______________________________________________________________________________ 
Intercept 10.317 15.547*** 
Birth weight 0.003 0.006** 
Day of Life -0.064 -3.201** 
BW X Day of Life -0.0001 -3.631*** 
Days HPF 0.16 3.949*** 
Days TPF -0.029 -1.056 
______________________________________________________________________________ 
Note: df’s = 110, except for df’s = 1505 for last two coefficients. 
^ p < .10. * p < .05. **P < .01. *** P < .001.  
 
Table 10: Blood urea nitrogen >20  
Variable n [n(%)] p Value 
Baseline 344 11 (3.2) 0.254 
TPF 77 0 (0)  
HPF 49 2 (4.1)  
Using Chi-Squared  ^ p < .10. * p < .05.  
All BUN values were evaluated once infants were on full feedings. The BUN values were 
then grouped by what formula the infant was receiving when that lab was taken, TPF, HPF, or 
other used to establish the baseline. When chi-squared test was used to evaluate if infants on the 
high protein preterm formula had BUN >20 mg/dL more often than infants receiving the 
traditional preterm formula or infants receiving breast milk or another formula no difference was 
found, p = 0.254.   
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Section 4 – Summary  
Overall there were no significant differences between the two study groups with the 
exception of discharge weight being higher in the TPF group. Although not significant, infants in 
the TPF group also had a mean longer length of stay by approximately 10 days and were more 
likely to be diagnosed with late onset sepsis.  
Using modeling to compare traditional preterm formula, and high protein preterm 
formula, to growth and protein status there were significant increases in growth and BUN 
associated with the number of days the  infants were receiving the high protein preterm formula 
with no adverse outcomes. 
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CHAPTER V 
 
 
CONCLUSIONS AND DISCUSSION 
 
 
 
Section 1 – Conclusions  
Infants in both groups were similar with the majority of infants being classified as white 
with a mean gestational age of ~31 ± SD of 3.2 weeks.  There were no differences in morbidity or 
mortality with the exception of sepsis being more prevalent in the traditional group.  The infants 
in TPF group were discharged at a higher weight, but were also admitted to the unit for longer 
periods of time. This could be due to the higher protein formula leading to not just better growth, 
but also improved health leading to faster discharge.  Overall there was the expected 
improvement in growth of 8.4 grams per day with every day an infant remained on the higher 
protein product.  It appears that the higher protein product lead to both shorter stays and better 
daily growth, important findings, both for the health of the infants and the costs to the medical 
care system.
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Section 2 – Relationship of findings to the literature 
Promoting growth:  
Many premature infants experience postnatal growth failure (Ziegler, 2007). Preterm 
infants are at a disadvantage as they have to grow outside the uterus. The goal of nutritional care 
for preterm infants is to promote growth at the same rate as an infant of the same gestational age 
in utero (AAP, 2009). Adequate nutrition to promote growth is essential in prevention of 
postnatal growth failure and also promotes optimal neurodevelopmental outcomes (Zielger, 
2007). Early nutrition not only prevents growth failure it also promotes accrual of lean body 
mass,  and increased mass in organs such as the brain, minimizing detrimental cognitive 
outcomes (Abernethy et al., 2004; Ehrenkranz et al., 2006; Ehrenkranz, 2000; Smart, 1990).  
With proper nutrition preterm infants have the ability to prevent extrauterine growth failure, and 
even obtain catch up growth in weight, length and head circumference indicating the brain too is 
catching-up (Isaacs et al., 2008).  This study indicates that the higher level protein  formula 
promotes achievement of these outcomes with better daily weight gain and shorter length of 
stays. However the study was not designed to determine the composition of the weight gain  
Further research will be needed to determine if infants gain lean mass or fat. 
Traditional preterm formula or fortified breast milk is not concentrated enough to meet 
the ESPGHAN 2010 goals of 4-4.5 grams protein per kilogram.   High protein preterm formula 
boost protein intake to 4.2 gram pro/kg to meet the higher estimated need for growth and 
development. This study shows that this increase in protein did promote weight gain in the infants 
receiving the high protein formula while there was no difference in weight gain between the other 
two options.  
Preventing morbidity: 
Those infants at particular risk for feeding difficulties are those that are less than 32 
weeks gestation and/or very low birth weight infants. These two groups are at an increased risk 
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for necrotizing enterocolitis (NEC) and last onset sepsis (Cloherty et al., 2008).  Both of these 
morbidities can negatively affect growth, so providing a formula that promotes growth, but 
increases the likelihood of morbidity or mortality is suboptimal. This study evaluated the effect of 
high protein preterm formula on these conditions and found no difference between groups in 
terms of NEC and mortality. The infants in the traditional preterm formula group were marginally 
significantly (p = 0.088)  septic more often, indicating that the high protein preterm formula did 
not cause more late onset sepsis, and might even have improved outcomes.  
With normal renal function a low BUN indicates inadequate protein intake. Very high 
BUN levels suggest possible excessive protein intake (Arslanoglu et al., 2006). Monitoring BUN 
can help to detect inadequate protein intake and be used to identify when excessive protein is 
being provided (Arslanoglu et al., 2006). Normal range for BUN in preterm infants in not well 
defined, according to Moyer-Mileur in Nutritional Care for High-Risk Newborns, 2000, 3-25 
mg/dl is an acceptable range for preterm infants ≤ 1 week old.  Other studies that have used BUN 
as a protein indicator set the ideal range for BUN from 9-14mg/dl, with > 20mg/dl considered as 
high (Arslanoglu et al., 2006). Providing excessive protein could lead to metabolic stress from 
protein overload (Tsang et al., 2005), increase in ammonia, blood amino acids, and an increase in 
late metabolic acidosis (Raiha, Heinonen, Rassin & Gaull, 1976).  While this study did not 
evaluate these markers BUN was examined. There was a positive increase in BUN when the high 
protein formula was used however there was not an increased numbers of infants with a high risk  
in BUN( being > 20 mg/dL) .Thus it likely that the high protein formula is a safe product that 
promotes improved protein status. However further research may be necessary determine if there 
is a risk of excessive protein intake.  
Section 3: Implications 
 This study shows that theoretical outcomes for increasing the protein content in preterm 
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formula hold true for the infants admitted to the NICU at S.t John’s Medical Center during the 
study period. Improving growth in these infants with no adverse outcomes could potentially lead 
to infants that are discharged from NICU’s with just not improved daily weight gain and 
potentially larger head circumferences indicating improved brain development but also shorted 
length of stays in the unit. Further study is indicated to assure that providing increased protein to 
promote growth does not lead to excessive BUN and  an increased incidence of kidney injury. 
However, this study shows the improvement in growth with no adverse outcomes.  
Section 4: Research Questions 
 The hypothesis of this study is that those infants in the high protein preterm 
formula group will show better overall growth with no adverse outcomes. The specific objectives 
of the study were:  
I. To evaluate the effect of high protein preterm formula related to the promotion of 
improved growth in the preterm infants admitted to the Saint John Medical Center 
NICU.  Expected outcomes will be: improved growth and a decrease in infants with 
extrauterine growth restriction as measured by differences in growth plotted on the 
Fenton growth chart from birth to discharge.  
II. To evaluate changes in biochemical markers of protein status in preterm infants on 
different feeding regimens.  With an increase in protein provided, improvements in 
blood urea nitrogen (BUN) are expected. Once the infant is on a stable fluid regimen 
and receiving full feeds the BUN should remain stable and indicate if the infant is 
receiving adequate amounts of protein.  
III. Morbidity outcomes such as length of stay and incidence of necrotizing enterocolitis 
will be evaluated. Mortality will also be evaluated.  
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Objective I 
While growth was improved when the high protein preterm formula was used there was 
not a reduction in EUGR rates.  
 Overall the hypothesis that the use of high protein preterm formula would show positive 
outcomes for weight gain was confirmed.  
Objective II 
Blood urea nitrogen was the biochemical marker used in this study to predict protein 
stores. There was an overall improvement in BUN in infant receiving the high protein preterm 
formula compared to other feeding type groups. While there was an increase in BUN, there was 
not an increased  likelihood that an infant on high protein preterm formula would have BUN 
levels >20 indicating no adverse outcomes associated with the  increased protein content of the 
formula.   
Objective III 
No differences between the groups were seen in terms of NEC and broncopulmonary 
dysplasia. There was an increase in late onset sepsis in group 1 indicating those infants may have 
been sicker overall, that same group also had a longer length of stay which likely explains why 
the infants were discharged at a higher weight than the infants in the high protein preterm formula 
group.     
   
Section 5: Limitations and Further Research 
One of the most significant limitations of this study was that it retrospectively evaluated 
infants during their admission.  Alterations had to be made to what indicators were collected as 
large amounts of information that would have be helpful for this study were not reported in the 
electronic medical record. The PI was limited to collecting data from what was reported in the 
chart. Information like discharge length was unavailable and therefore could not be analyzed. In a 
prospective study the groups could be randomly assigned to the treatment group with high protein 
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preterm formula or the control of preterm formula. In this study very few infants in either group 
were solely on one formula. Most transitioned at least once if not several time from breast milk to 
one preterm formula or specialized formula or another during their admission.  For example an 
infants trophic feeds would be initialed with preterm formula until the mothers breast milk came 
in, at that time they would transition to a mixture of breast milk and preterm formula.  Often 
times an infant would then be transitioned back to preterm formula if the mothers supply ran low, 
or she was unable to maintain supply and opted to formula feed.  To more clearly see the effect of 
the high protein formula having a group receive only that formulation would be beneficial. 
Analysis of body composition would have shown if the increase in weight gain was attributed to 
accruing lean body mass or fat mass. If the product simply creates “fatter” infants it likely would 
not me beneficial for broad use in a community NICU with varying ages and sizes of infants. 
While continuous data was collected on head circumference analysis of that data is outside the 
scope of this report.  This information likely would have provided a clearer picture on brain 
development in this population. This study had a relatively small sample size, effects likely would 
have been more pronounced if the groups were larger.  
Another limitation is the high likelihood that standard practice by the neonatologist and 
nurses in this unit changed from one group to the next due to the extended period of the study. 
Particularly because there is not a standardized feeding regimen in place at St. John NICU.  
Having such a protocol would have made it easier to define changes in outcomes. Without a 
standardized time line, there is an increase in variability in timing and feeding advancement from 
infant to infant, both of which can affect growth and outcomes.  
Indications for future research include further investigation of the effects of increasing 
the amount of protein. This could also include the composition of the protein provided in the 
formula.  Closer evaluation of composition of weight gain is essential for the promotion of a 
product such as high protein preterm formula. While there were no differences in morbidity or 
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mortality, investigation with the sole use of products such as the high protein preterm formula 
compared to a standard such as breast milk could be beneficial.  
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APPENDICES I  
LIST OF ABREVIATIONS 
 
 
 
 
 
SJMC- St. John Medical Center 
NICU- neonatal intensive care unit 
GA- gestational age- first day of the woman’s last menstrual cycle to the delivery date, measured in weeks 
AGA- appropriate for gestational age- 10-90% for gestational age at birth 
SGA- small for gestational age- less than 10% for gestational age at birth 
IUGR- intrauterine growth restriction- less than 10% for gestational age with evidence of restriction due to 
pathological process in womb 
EUGR- extrauterine growth restriction- birth weight that is appropriate for gestational age but by the time 
of hospital discharge weight is less than the 10% for corrected gestational age 
Preterm- infants born before 37 completed weeks of gestational age 
BW- birth weight  
LBW- less than 2500 grams 
VLBW- very low birth weight- less than 1500 grams  
ELBW- extremely low birth weight- less than 1000 grams 
TPF- traditional preterm formula- formula designed especially for preterm infants typically more highly 
concentrated in calories and protein.  
HPF- high protein preterm formula- higher concentration of protein than preterm formula at same volume 
or concentration  
EBM- expressed breast milk 
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Full feeds- infants are receiving all nutrition from formula or EBM, parenteral nutrition support 
discontinued, typically receiving feedings of 120-150 ml/kg.  
Trophic feeds- nonnutritive feeds used to prime the gut, 1-25 ml/kg 
NPO- nothing by mouth 
TPN- Total parenteral nutrition- dextrose, amino acids, and fat provided via central line 
FOC- Fronto-occipital circumference or head circumference 
BUN- blood urea nitrogen, normal levels 3-25 mg/dL  
Cr- creatinine  
DOL- day of life 
LOS- length of stay 
D/C- discharge 
NEC- necrotizing enterocolitis- an inflammatory necrosis of bowel 
Late onset sepsis- blood infection that occurs between days 8 and 90 
BPD- broncopulmonary dysplasia- infant less than 32 weeks gestation remaining on oxygen 
support for more than 28 days 
CLD- chronic lung disease- infant remaining on oxygen support for more than 28 days 
EMR- electronic medical record 
AAP- American Academy of Pediatrics  
ESPGHAN- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 
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Conclusion:  The higher protein formula lead to better daily growth and improvements in 
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